Training courses in public speaking and/or organizations such as
Australian Rostrum,
Toastmasters International, POWERtalk International, and
Association of Speakers Clubs or
cultural activities at school level can help people to reduce their fear of public speaking to manageable levels. In some cases, anxiety can be mitigated by a speaker not attempting to resist their anxiety, thus fortifying the anxiety/fight-or-flight loop. Other strategies involve using one's nervousness to enliven an otherwise fearful speech presentation. Traditional advice has been to urge fearful speakers not to take themselves too seriously, and to be reminded that mistakes are often unnoticed by audiences. Gaining experience in public speaking often results in it becoming less anxiety-provoking over time. Recent studies suggest that there is a close link between fear of public speaking and self-efficacy and that attempts to help presenters improve their
self-efficacy will also reduce this fear. Loosening up a "tough crowd" by asking questions promotes audience participation. A speaker may also find this exercise to be helpful when their mind "goes blank", as it gives them time to regain their
train of thought.
Medication Beta-blockers are commonly prescribed off-label to mitigate the immediate physical reactions associated with anxiety, including glossophobia. These medications act by blocking the effects of
adrenaline, thereby reducing symptoms such as rapid heartbeat, trembling, and sweating.
Propranolol, in particular, has been noted for its efficacy in managing
stage fright and is widely used among performers and public speakers.
Benzodiazepines (e.g., lorazepam, clonazepam) are fast-acting anxiolytics medications that can help in acute, high-stress situations. They function by enhancing the effect of the neurotransmitter
GABA, producing a calming effect. However, they carry risks of toxicity and physical dependency, and are generally reserved for short-term or occasional use.
Selective Serotonin Reuptake Inhibitors (SSRIs), including
sertraline and
paroxetine, are commonly prescribed for generalized social anxiety disorder. These medications work by increasing
serotonin levels in the brain, which can help improve mood and reduce anxiety over time. Unlike beta-blockers and benzodiazepines, SSRIs require several weeks to achieve therapeutic effects and are typically used as long-term treatment options.
Psychotherapy Cognitive Behavioral Therapy (CBT) is a widely recognized and effective treatment for glossophobia, particularly when the condition is associated with social anxiety disorder. CBT focuses on identifying and challenging negative thought patterns associated with public speaking anxiety, and replacing them with more positive and realistic beliefs. The approach often includes
exposure therapy, in which individuals confront feared social situations either through real-life exposure (in vivo) or imagined scenarios (in vitro), to reduce anxiety and improve their public speaking performance. While CBT has demonstrated effectiveness, both in vivo and in vitro exposure methods can present challenges, such as high time and resource requirements, limited environmental control, and difficulties some individuals face in visualizing anxiety-provoking situations. One study reported that CBT combined with
virtual reality exposure significantly reduced public speaking anxiety, with improvements maintained at a three-month follow-up. Another study found that while both CBT and VRCBT significantly reduced public speaking anxiety, twice as many clients dropped out of CBT (15) than from VRCBT (6).
Virtual reality exposure therapy (VRET) As an alternative to in vivo and in vitro exposure therapy, VRET has emerged as an effective intervention for individuals experiencing glossophobia and it overcomes some of the limitations of traditional CBT. VRET simulates public speaking scenarios and evokes anxiety responses comparable to real-world experiences, enabling gradual
desensitization within a safe setting. Recent technological advancements have enabled the development of self-guided and automated VRET platforms that do not require direct clinician involvement. Growing evidence supports the effectiveness of such approaches, where one study found that self-guided VRET produced similar reductions in public speaking anxiety compared to those achieved through therapist-led sessions. Innovations in VRET design have focused on user engagement. Dr. Chris Macdonald from the University of Cambridge developed an open-access VR platform compatible with smartphones, headsets and laptops. The system immerses users in simulated speaking environments with gradual exposure to anxiety-inducing stimuli, ranging from small classrooms to large stadium with 10,000 highly-distracting virtual spectators. A single 30 minute session experiment with 29 adolescents reported a substantial reduction in public speaking anxiety using the VR platform. While most research on VRET for glossophobia has focused on adult populations, there are studys targeting adolescents, who may be less likely to seek formal treatment for anxiety-related issues. A gamified VRET program was developed specifically for teenagers, combining traditional exposure techniques with game elements such as rewards, goal-setting, and challenges to enhance engagement and reduce dropout rates. A pilot study found that this approach led to significant reductions in public speaking anxiety compared to a waitlist control group, highlighting the potential of gamification to enhance both engagement and treatment outcomes in teenagers. == Epidemiology ==